Back to Journals » Vascular Health and Risk Management » Volume 16

Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review

Authors Watanabe J, Kotani K

Received 13 January 2020

Accepted for publication 5 April 2020

Published 17 April 2020 Volume 2020:16 Pages 149—155

DOI https://doi.org/10.2147/VHRM.S245829

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Takashi Kajiya


Jun Watanabe, Kazuhiko Kotani

Center for Community Medicine, Jichi Medical University, Shimotsuke-City, Japan

Correspondence: Kazuhiko Kotani
Center for Community Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-City, Tochigi 329-0498, Japan
Tel +81-285-58-7394
Fax +81-285-44-0628
Email kazukotani@jichi.ac.jp

Background: The importance of management of metabolic syndrome (MetS) for risk reduction of cardiovascular disease (CVD) has been recognized worldwide. Because of the comparatively unique characteristics of bodily figure/obesity and incident CVD in Japan, the relevance of MetS on CVD can be still discussed among Japanese people. The present study aimed to review briefly the relationship of MetS with CVD morbidity/mortality among general Japanese people.
Methods: Population-based prospective cohort studies evaluating the predictive value of MetS on CVD morbidity/mortality via a PubMed search up to 2019 were summarized.
Results: We identified two studies on morbidity that reported MetS to predict CVD morbidity. We identified three studies on mortality, and these studies showed an increased direction of hazard ratio (HR) of CVD mortality, while one study reported an insignificant prediction of MetS for CVD mortality. In the meta-analysis method, MetS significantly predicted CVD morbidity (HR=1.71 [95% confidence interval=1.34– 2.18] in men and HR=1.89 [95% confidence interval=1.45– 2.46] in women) as well as CVD mortality (HR=1.68 [95% confidence interval=1.37– 2.06] in men and HR=1.73 [95% confidence interval=1.39– 2.15] in women).
Conclusion: Among general Japanese people, MetS can be a positive predictor of CVD morbidity/mortality. Since the studies are limited, more research is needed to establish the findings.

Keywords: cardiometabolic health, disease morbidity, disease mortality, obesity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]